Literature DB >> 23023711

Molecular genetics of B-precursor acute lymphoblastic leukemia.

Charles G Mullighan1.   

Abstract

B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and the leading cause of cancer-related death in children and young adults. The majority of B-ALL cases are aneuploid or harbor recurring structural chromosomal rearrangements that are important initiating events in leukemogenesis but are insufficient to explain the biology and heterogeneity of disease. Recent studies have used microarrays and sequencing to comprehensively identify all somatic genetic alterations in acute lymphoblastic leukemia (ALL). These studies have identified cryptic or submicroscopic genetic alterations that define new ALL subtypes, cooperate with known chromosomal rearrangements, and influence prognosis. This article reviews these advances, discusses results from ongoing second-generation sequencing studies of ALL, and highlights challenges and opportunities for future genetic profiling approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023711      PMCID: PMC3461902          DOI: 10.1172/JCI61203

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  121 in total

1.  Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

Authors:  Andishe Attarbaschi; Georg Mann; Renate Panzer-Grümayer; Silja Röttgers; Manuel Steiner; Margit König; Eva Csinady; Michael N Dworzak; Markus Seidel; Dasa Janousek; Anja Möricke; Carsten Reichelt; Jochen Harbott; Martin Schrappe; Helmut Gadner; Oskar A Haas
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 2.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

3.  The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1.

Authors:  Helen Parker; Qian An; Kerry Barber; Marian Case; Teresa Davies; Zoë Konn; Adam Stewart; Sarah Wright; Mike Griffiths; Fiona M Ross; Anthony V Moorman; Andy G Hall; Julie A Irving; Christine J Harrison; Jon C Strefford
Journal:  Genes Chromosomes Cancer       Date:  2008-12       Impact factor: 5.006

4.  Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.

Authors:  Jun J Yang; Deepa Bhojwani; Wenjian Yang; Xiangjun Cai; Gabriele Stocco; Kristine Crews; Jinhua Wang; Debra Morrison; Meenakshi Devidas; Stephen P Hunger; Cheryl L Willman; Elizabeth A Raetz; Ching-Hon Pui; William E Evans; Mary V Relling; William L Carroll
Journal:  Blood       Date:  2008-09-02       Impact factor: 22.113

5.  Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Motohiro Kato; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

6.  MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.

Authors:  M C Stubbs; Y M Kim; A V Krivtsov; R D Wright; Z Feng; J Agarwal; A L Kung; S A Armstrong
Journal:  Leukemia       Date:  2007-09-13       Impact factor: 11.528

7.  Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Kajsa Paulsson; Andrea Horvat; Bodil Strömbeck; Fredrik Nilsson; Jesper Heldrup; Mikael Behrendtz; Erik Forestier; Anna Andersson; Thoas Fioretos; Bertil Johansson
Journal:  Genes Chromosomes Cancer       Date:  2008-01       Impact factor: 5.006

8.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

9.  H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

Authors:  Andrei V Krivtsov; Zhaohui Feng; Madeleine E Lemieux; Joerg Faber; Sridhar Vempati; Amit U Sinha; Xiaobo Xia; Jonathan Jesneck; Adrian P Bracken; Lewis B Silverman; Jeffery L Kutok; Andrew L Kung; Scott A Armstrong
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

10.  Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.

Authors:  Dani Bercovich; Ithamar Ganmore; Linda M Scott; Gilad Wainreb; Yehudit Birger; Arava Elimelech; Chen Shochat; Giovanni Cazzaniga; Andrea Biondi; Giuseppe Basso; Gunnar Cario; Martin Schrappe; Martin Stanulla; Sabine Strehl; Oskar A Haas; Georg Mann; Vera Binder; Arndt Borkhardt; Helena Kempski; Jan Trka; Bella Bielorei; Smadar Avigad; Batia Stark; Owen Smith; Nicole Dastugue; Jean-Pierre Bourquin; Nir Ben Tal; Anthony R Green; Shai Izraeli
Journal:  Lancet       Date:  2008-09-19       Impact factor: 79.321

View more
  93 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

Review 2.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

3.  Effect of GSTM1 null genotype on risk of childhood acute leukemia: a meta-analysis.

Authors:  Yan Ma; Yun Sui; Lizhen Wang; Huirong Li
Journal:  Tumour Biol       Date:  2014-01

Review 4.  Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.

Authors:  Nicholas R Harrison; Fabrice J F Laroche; Alejandro Gutierrez; Hui Feng
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  Apoptosis pathway signature for prediction of treatment response and clinical outcome in childhood high risk B-Precursor acute lymphoblastic leukemia.

Authors:  Ya-Hsuan Chang; Yung-Li Yang; Chung-Ming Chen; Hsuan-Yu Chen
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

6.  Murine B-1 B cell progenitors initiate B-acute lymphoblastic leukemia with features of high-risk disease.

Authors:  Encarnacion Montecino-Rodriguez; Katy Li; Michael Fice; Kenneth Dorshkind
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

7.  The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns.

Authors:  Daniel Hein; Karin Dreisig; Markus Metzler; Shai Izraeli; Kjeld Schmiegelow; Arndt Borkhardt; Ute Fischer
Journal:  Blood       Date:  2019-10-17       Impact factor: 22.113

8.  MLL rearranged acute lymphoblastic leukaemia presenting as a maxillary sinus mass with a discordant immunophenotypic profile from the bone marrow.

Authors:  Yunzu Michele Wang; Jun Qin Mo; Dennis John Kuo; Victor Wong
Journal:  BMJ Case Rep       Date:  2019-02-15

9.  Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline.

Authors:  Valérie de Haas; Nofisat Ismaila; Anjali Advani; Daniel A Arber; Raetasha S Dabney; Dipti Patel-Donelly; Elizabeth Kitlas; Rob Pieters; Ching-Hon Pui; Kendra Sweet; Ling Zhang
Journal:  J Clin Oncol       Date:  2018-12-03       Impact factor: 44.544

10.  Centrosome Aberration Frequency and Disease Association in B-Acute Lymphoblastic Leukemia.

Authors:  Lily S Kerketta; Kanjaksha Ghosh; Anita Nadkarni; Manisha Madkaikar; Babu Rao Vundinti
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.